
GBP 30mg Capsule SR
Marketer
Greenco Biologicals Pvt Ltd
Salt Composition
Domperidone (30mg)
Overview GBP 30mg Capsule SR
Thirty-milligram GBP sustained-release capsules treat indigestion, nausea, and vomiting. This medication accelerates gastrointestinal transit, alleviating bloating, satiety, and stomach upset. Administer one capsule thirty minutes prior to meals, following your physician's prescribed dosage and duration. Treatment length and dosage are individualized based on your response. Continue until your doctor advises discontinuation. Inform your doctor of all concurrent medications, as interactions are possible. Headache, dry mouth, and abdominal pain are common, usually transient side effects. Report any concerning side effects immediately. Dizziness may occur; avoid driving or activities requiring alertness until effects are known. Alcohol consumption should be avoided due to potential side effect exacerbation. Diarrhea is a possibility; increased fluid intake is recommended to prevent dehydration. Disclose liver or kidney issues before starting this treatment. Avoid concurrent antacid use. Pregnant individuals require medical consultation before use. This medication is contraindicated for those with active peptic ulcers.
Uses of GBP 30mg Capsule SR
Managing indigestion, nausea, and vomiting.
Major Benefits of GBP 30mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The 30mg GBP SR capsule should be swallowed whole, without chewing, crushing, or breaking. Administer on an empty stomach.
Common Side effects of GBP 30mg Capsule SR:
- Headache
- Dryness in mouth
- Stomach pain
- Diarrhea
How to use GBP 30mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 30mg GBP SR capsule whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How GBP 30mg Capsule SR works:
Thirty-milligram, sustained-release GBP capsules are a gastrointestinal motility stimulant. They exert their effect by acting on the brain's emetic center, suppressing nausea and vomiting. Concurrently, they enhance gastric and intestinal motility in the upper digestive tract, facilitating smoother food passage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside GBP 30mg Capsule SR is unstudied regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of 30mg extended-release GBP capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against the risks before prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingSAFE IF PRESCRIBED
Extended-release 30mg capsules of GBP are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking a 30mg sustained-release GBP capsule can reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when administering 30mg sustained-release GBP capsules to individuals with renal impairment. Dosage modification of 30mg sustained-release GBP capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking GBP 30mg sustained-release capsules. Dosage modification may be necessary. Physician consultation is advised. GBP 30mg sustained-release capsules are contraindicated for patients experiencing moderate to severe hepatic dysfunction.
What if you forget to take GBP 30mg Capsule SR :
Should you forget a dose of your 30mg GBP sustained-release capsule, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About GBP 30mg Capsule SR
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Prokinetic agent with dopamine D2 receptor antagonism |
